Trial Profile
A Phase 3, Open-label, Randomized, Multi-center, Controlled Trial to Evaluate the Pharmacokinetics and Pharmacodynamics of Edoxaban and to Compare the Efficacy and Safety of Edoxaban With Standard of Care Anticoagulant Therapy in Pediatric Subjects From Birth to Less Than 18 Years of Age With Confirmed Venous Thromboembolism (VTE)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Feb 2024
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary) ; Acenocoumarol; Enoxaparin sodium; Fondaparinux sodium; Heparin; Nadroparin calcium; Warfarin
- Indications Venous thromboembolism
- Focus Registrational; Therapeutic Use
- Sponsors Daiichi Sankyo Inc
- 28 Jun 2022 Planned number of patients changed from 274 to 290.
- 28 Jun 2022 Status changed from recruiting to completed.
- 04 May 2022 Planned End Date changed from 31 Aug 2022 to 24 May 2022.